Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4733-39-5

Post Buying Request

4733-39-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4733-39-5 Usage

Classification

Electron-transport layer materials, Electron-injection layer materials, Hole-blocking layer materials, OFET, OLED, Organic Photovoltaics, Perovskite solar cells, Sublimed materials.

Applications

2,9-Dimethyl-4,7-diphenyl-1,10-phenanthroline, also known as Bathocuproine (BCP), is a wide-band-gap material and has a high electron affinity. When it is embedded into organic electronic devices, bathocuproine acts as an exciton-blocking barrier which prohibits exciton diffusion process towards the Al electrode otherwise being quenched. One of the most commonly used buffer layer between acceptor and cathode layers is bathocuproine. The introduction of the buffer layer can greatly improve the PCE of polymer organic solar cells. BCP is one of the most popular hole-blocking layer materials that is used in organic electronics, including perovskite solar cells. It was demonstrated that a BCP buffer layer reduces nonradiative recombination of excitons at the C60 –Al interface. Its most important function is to establish an Ohmic contact between the C60 film and the Al electrode in photovoltaic devices.

Description

Bathocuproine (BCP) is a wide-band-gap material and has a high electron affinity. When it is embedded into organic electronic devices, bathocuproine acts as an exciton-blocking barrier?which prohibits exciton diffusion process?towards the Al electrode otherwise being quenched. One of the most commonly used buffer layer between acceptor and cathode layers is?bathocuproine. The introduction of the buffer layer can greatly improve the PCE of polymer organic solar cells.?BCP is one of the most popular hole-blocking layer materials that is used in organic electronics, including perovskite solar cells.

Chemical Properties

Yellow powder

Uses

Different sources of media describe the Uses of 4733-39-5 differently. You can refer to the following data:
1. It is used as a reagent for the determination of copper. It acts as an exciton blocking barrier which prohibits excitons diffusion process towards the Al electrode otherwise being quenched. It is the most commonly used buffer layer between acceptor and cathode layer.
2. Bathocuproine is used as a reagent for the determination of copper. It acts as an exciton blocking barrier which prohibits excitons diffusion process towards the Al electrode otherwise being quenched. It is the most commonly used buffer layer between acceptor and cathode layer.

General Description

TGA/DSC Lot specific scans available upon request

Purification Methods

Purify it by recrystallisation from *benzene. [Smith & Wilkins Anal Chem 25 510 1953, Beilstein 23 III/IV 2160.]

Check Digit Verification of cas no

The CAS Registry Mumber 4733-39-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,3 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4733-39:
(6*4)+(5*7)+(4*3)+(3*3)+(2*3)+(1*9)=95
95 % 10 = 5
So 4733-39-5 is a valid CAS Registry Number.
InChI:InChI=1/C26H20N2/c1-17-15-23(19-9-5-3-6-10-19)21-13-14-22-24(20-11-7-4-8-12-20)16-18(2)28-26(22)25(21)27-17/h3-16H,1-2H3

4733-39-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B2694)  Bathocuproine (purified by sublimation)  >99.0%(HPLC)(T)

  • 4733-39-5

  • 1g

  • 1,490.00CNY

  • Detail
  • TCI America

  • (B2694)  Bathocuproine (purified by sublimation)  >99.0%(HPLC)(T)

  • 4733-39-5

  • 5g

  • 5,200.00CNY

  • Detail
  • TCI America

  • (D0711)  Bathocuproine  >98.0%(T)

  • 4733-39-5

  • 1g

  • 990.00CNY

  • Detail
  • TCI America

  • (D0711)  Bathocuproine  >98.0%(T)

  • 4733-39-5

  • 5g

  • 3,450.00CNY

  • Detail
  • Alfa Aesar

  • (B22841)  Bathocuproin, 98%   

  • 4733-39-5

  • 1g

  • 655.0CNY

  • Detail
  • Alfa Aesar

  • (B22841)  Bathocuproin, 98%   

  • 4733-39-5

  • 5g

  • 2724.0CNY

  • Detail
  • Aldrich

  • (699152)  Bathocuproine  sublimed grade, 99.99% trace metals basis

  • 4733-39-5

  • 699152-500MG

  • 1,993.68CNY

  • Detail
  • Aldrich

  • (699152)  Bathocuproine  sublimed grade, 99.99% trace metals basis

  • 4733-39-5

  • 699152-5G

  • 14,110.20CNY

  • Detail
  • Aldrich

  • (140910)  Bathocuproine  96%

  • 4733-39-5

  • 140910-500MG

  • 661.05CNY

  • Detail
  • Aldrich

  • (140910)  Bathocuproine  96%

  • 4733-39-5

  • 140910-1G

  • 1,078.74CNY

  • Detail

4733-39-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline

1.2 Other means of identification

Product number -
Other names 4,7-diphenyl-2,9-dimethyl-1,10-phenanthroline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4733-39-5 SDS

4733-39-5Synthetic route

2,9-dimethyl 4,7-dichloro-1,10-phenanthroline

2,9-dimethyl 4,7-dichloro-1,10-phenanthroline

phenylboronic acid
98-80-6

phenylboronic acid

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In tetrahydrofuran; water for 24h; Suzuki-Miyaura Coupling; Reflux; Inert atmosphere;98%
2-methyl-8-nitro-4-phenyl-quinoline
70205-01-5

2-methyl-8-nitro-4-phenyl-quinoline

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
Hydrogenation.Erhitzen des erhaltenen Amins mit 1-Phenyl-but-2-en-1-on, sirupoese H3PO4 und H3AsO4;
1-phenylbut-2-en-1-one
495-41-0

1-phenylbut-2-en-1-one

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: arsenic acid; zinc-chloride; aqueous hydrochloric acid
2: Hydrogenation.Erhitzen des erhaltenen Amins mit 1-Phenyl-but-2-en-1-on, sirupoese H3PO4 und H3AsO4
View Scheme
2-nitro-aniline
88-74-4

2-nitro-aniline

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: arsenic acid; zinc-chloride; aqueous hydrochloric acid
2: Hydrogenation.Erhitzen des erhaltenen Amins mit 1-Phenyl-but-2-en-1-on, sirupoese H3PO4 und H3AsO4
View Scheme
1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 0.25 h / Reflux
1.2: 2 h / Reflux
2.1: diphenylether / 0.67 h / 240 - 260 °C
3.1: trichlorophosphate / 3.5 h / 90 °C / Inert atmosphere
4.1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / water; tetrahydrofuran / 24 h / Reflux; Inert atmosphere
View Scheme
5,5'-((1,2-phenylenebis(azanediyl))bis(ethan-1-yl-1-ylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-dione)
1311162-31-8

5,5'-((1,2-phenylenebis(azanediyl))bis(ethan-1-yl-1-ylidene))bis(2,2-dimethyl-1,3-dioxane-4,6-dione)

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: diphenylether / 0.67 h / 240 - 260 °C
2: trichlorophosphate / 3.5 h / 90 °C / Inert atmosphere
3: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / water; tetrahydrofuran / 24 h / Reflux; Inert atmosphere
View Scheme
C37H25MnN6O4

C37H25MnN6O4

A

carbon monoxide
201230-82-2

carbon monoxide

B

Bathocuproine
4733-39-5

Bathocuproine

C

4-(1H-1,2,3,4-tetrazol-5-yl)benzaldehyde
74815-22-8

4-(1H-1,2,3,4-tetrazol-5-yl)benzaldehyde

Conditions
ConditionsYield
In dichloromethane UV-irradiation;
C36H25MnN6O3

C36H25MnN6O3

A

5-Phenyl-1H-tetrazole
18039-42-4

5-Phenyl-1H-tetrazole

B

carbon monoxide
201230-82-2

carbon monoxide

C

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
In dichloromethane UV-irradiation;
C35H24MnN7O3

C35H24MnN7O3

A

3-(1H-tetrazol-5-yl)pyridine
3250-74-6

3-(1H-tetrazol-5-yl)pyridine

B

carbon monoxide
201230-82-2

carbon monoxide

C

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
In dichloromethane UV-irradiation;
C35H24MnN7O3

C35H24MnN7O3

A

5-(4-pyridyl)tetrazole
14389-12-9

5-(4-pyridyl)tetrazole

B

carbon monoxide
201230-82-2

carbon monoxide

C

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
In dichloromethane UV-irradiation;
C37H24MnN7O3

C37H24MnN7O3

A

5-(4-cyanophenyl)tetrazole
14389-10-7

5-(4-cyanophenyl)tetrazole

B

carbon monoxide
201230-82-2

carbon monoxide

C

Bathocuproine
4733-39-5

Bathocuproine

Conditions
ConditionsYield
In dichloromethane UV-irradiation;
tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

Bathocuproine
4733-39-5

Bathocuproine

bis[2-(diphenylphosphino)phenyl] ether
166330-10-5

bis[2-(diphenylphosphino)phenyl] ether

2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline bis[(2-diphenyl-phosphino)phenyl]ether copper(I) hexafluorophosphate
1421057-27-3

2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline bis[(2-diphenyl-phosphino)phenyl]ether copper(I) hexafluorophosphate

Conditions
ConditionsYield
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; bis[2-(diphenylphosphino)phenyl] ether In dichloromethane at 20℃; for 2h; Inert atmosphere;
Stage #2: Bathocuproine In dichloromethane for 1h; Inert atmosphere;
99%
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; bis[2-(diphenylphosphino)phenyl] ether In dichloromethane at 20℃; for 2h; Inert atmosphere;
Stage #2: Bathocuproine In dichloromethane for 1h;
91%
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; bis[2-(diphenylphosphino)phenyl] ether In dichloromethane Schlenk technique; Reflux;
Stage #2: Bathocuproine In dichloromethane at 20℃; Schlenk technique; Reflux;
85%
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; bis[2-(diphenylphosphino)phenyl] ether In dichloromethane at 20℃; for 2h;
Stage #2: Bathocuproine In dichloromethane at 20℃; for 1h;
43.8%
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; bis[2-(diphenylphosphino)phenyl] ether In dichloromethane at 20℃;
Stage #2: Bathocuproine In dichloromethane at 20℃;
tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

Bathocuproine
4733-39-5

Bathocuproine

nixantphos

nixantphos

[Cu(bathocuproine)(4,6-bis(diphenylphosphino)-10H-phenoxazine)]PF6
1421057-56-8

[Cu(bathocuproine)(4,6-bis(diphenylphosphino)-10H-phenoxazine)]PF6

Conditions
ConditionsYield
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; nixantphos In dichloromethane Schlenk technique; Reflux;
Stage #2: Bathocuproine In dichloromethane at 20℃; Schlenk technique; Reflux;
99%
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; nixantphos In dichloromethane at 20℃;
Stage #2: Bathocuproine In dichloromethane at 20℃;
Bathocuproine
4733-39-5

Bathocuproine

palladium diacetate
3375-31-3

palladium diacetate

(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)palladium(II) acetate
152506-88-2

(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)palladium(II) acetate

Conditions
ConditionsYield
With air In dichloromethane at 20℃;98%
In dichloromethane pptn. from diethyl ether;96%
In dichloromethane at 30℃; for 3h; Inert atmosphere;96%
NiCl2(bathocuproine)
120763-13-5

NiCl2(bathocuproine)

Bathocuproine
4733-39-5

Bathocuproine

C52H40N4Ni(1+)*Cl(1-)

C52H40N4Ni(1+)*Cl(1-)

Conditions
ConditionsYield
With cyclohexa-1,4-diene In acetonitrile Irradiation; Photolysis; Inert atmosphere; Glovebox;98%
[(η5-4,7-Me2C9H5)Mo(CO)2(NCMe)2][BF4]

[(η5-4,7-Me2C9H5)Mo(CO)2(NCMe)2][BF4]

Bathocuproine
4733-39-5

Bathocuproine

[(η5-4,7-Me2C9H5)-Mo(CO)2(2,9-Me2-4,7-Ph2-phen)][BF4]

[(η5-4,7-Me2C9H5)-Mo(CO)2(2,9-Me2-4,7-Ph2-phen)][BF4]

Conditions
ConditionsYield
In dichloromethane at 20℃; Inert atmosphere; Schlenk technique;98%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

rhenium(I) pentacarbonyl chloride
14099-01-5

rhenium(I) pentacarbonyl chloride

2,6-dimethylphenyl isonitrile
119072-54-7, 2769-71-3

2,6-dimethylphenyl isonitrile

Bathocuproine
4733-39-5

Bathocuproine

fac-[Re(CO)3(2,6-dimethylphenylisocyanide)(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)](PF6)
850813-85-3

fac-[Re(CO)3(2,6-dimethylphenylisocyanide)(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)](PF6)

Conditions
ConditionsYield
With AgCF3SO3 In ethanol byproducts: AgCl; addn. of Re(CO)5Cl to Me2Ph2-phen, addn. EtOH, reflux for 2 h; pptn., filtration at room temp., drying (vac.) for 3 h; addn. of AgCF3SO3 and EtOH, reflux for 4 h; cooling, pptn., filtration, addn. Me2C6H3NC/EtOH; reflux for 3 h; concn., addn. aq. NH4PF6; dilution with water, pptn., filtration, drying in vac. oven, elem. anal.;97%
(1,2-dimethoxyethane)dichloronickel(II)
29046-78-4

(1,2-dimethoxyethane)dichloronickel(II)

Bathocuproine
4733-39-5

Bathocuproine

NiCl2(bathocuproine)
120763-13-5

NiCl2(bathocuproine)

Conditions
ConditionsYield
In tetrahydrofuran at 23℃; for 10h; Inert atmosphere; Glovebox;96%
Bathocuproine
4733-39-5

Bathocuproine

palladium diacetate
3375-31-3

palladium diacetate

(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)-palladium(II) acetate

(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)-palladium(II) acetate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 3h;96%
(9,9-dimethyl-9H-xanthene-4,5-diyl)bis(dicyclohexylphosphane)

(9,9-dimethyl-9H-xanthene-4,5-diyl)bis(dicyclohexylphosphane)

tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

Bathocuproine
4733-39-5

Bathocuproine

[Cu(bathocuproine)((9,9-dimethyl-9H-xanthene-4,5-diyl)bis(dicyclohexylphosphine))]PF6
1421057-52-4

[Cu(bathocuproine)((9,9-dimethyl-9H-xanthene-4,5-diyl)bis(dicyclohexylphosphine))]PF6

Conditions
ConditionsYield
Stage #1: (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(dicyclohexylphosphane); tetrakis(actonitrile)copper(I) hexafluorophosphate In dichloromethane Schlenk technique; Reflux;
Stage #2: Bathocuproine In dichloromethane at 20℃; Schlenk technique; Reflux;
95%
Bathocuproine
4733-39-5

Bathocuproine

4,7-diphenyl-1,10-phenanthroline-2,9-dicarboxylic acid

4,7-diphenyl-1,10-phenanthroline-2,9-dicarboxylic acid

Conditions
ConditionsYield
Stage #1: Bathocuproine With selenium(IV) oxide In 1,4-dioxane; water for 3h; Reflux;
Stage #2: With nitric acid for 3h; Reflux;
94%
With dihydrogen peroxide at 80℃; for 8h;80%
Multi-step reaction with 2 steps
1: 76 percent / N-chlorosuccinimide, 3-chloroperbenzoic acid / CCl4; CHCl3 / 16 h / Heating
2: 89 percent / aq. formic acid / 24 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: N-chloro-succinimide; dibenzoyl peroxide / chloroform / 6 h / Reflux
2: sulfuric acid / 2 h / Microwave irradiation; Heating
View Scheme
tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

Bathocuproine
4733-39-5

Bathocuproine

bis(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)copper(I) hexafluorophosphate
47895-81-8

bis(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)copper(I) hexafluorophosphate

Conditions
ConditionsYield
In acetonitrile Ar-atmosphere; addn. of 2 equiv. of phen derivative to Cu-complex soln.,stirring for 10 min; pptn. on Et2O addn., filtration, dissoln. in CH2Cl2, crystn. on layeringwith Et2O; elem. anal.;94%
In methanol for 1h; Inert atmosphere;82%
for 0.333333h; Inert atmosphere;
NiCl2(bathocuproine)
120763-13-5

NiCl2(bathocuproine)

Bathocuproine
4733-39-5

Bathocuproine

Ni(bathocuproine)2
1508299-90-8

Ni(bathocuproine)2

Conditions
ConditionsYield
With 2,6-dimethylpyridine In tetrahydrofuran Irradiation; Inert atmosphere; Glovebox;94%
Bathocuproine
4733-39-5

Bathocuproine

2,9-bis(trichloromethyl)-4,7-diphenyl-1,10-phenanthroline

2,9-bis(trichloromethyl)-4,7-diphenyl-1,10-phenanthroline

Conditions
ConditionsYield
With N-chloro-succinimide; dibenzoyl peroxide In chloroform for 6h; Reflux;93%
With N-chloro-succinimide; dibenzoyl peroxide In chloroform for 24h; Reflux;80%
With N-chloro-succinimide; 3-chloro-benzenecarboperoxoic acid In tetrachloromethane; chloroform for 16h; Heating;76%
With N-chloro-succinimide; dibenzoyl peroxide In tetrachloromethane; chloroform6.1 g (97%)
Bathocuproine
4733-39-5

Bathocuproine

2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline N-oxide

2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline N-oxide

Conditions
ConditionsYield
With water; fluorine; acetonitrile In chloroform at 0℃;93%
tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

Bathocuproine
4733-39-5

Bathocuproine

4,5-bis(diphenylphosphino)-9,9-dimethylxanthene
161265-03-8

4,5-bis(diphenylphosphino)-9,9-dimethylxanthene

[Cu(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)(4,5-bis(diphenylphosphino)-9,9-dimethylxanthene)](PF6)
1421057-42-2

[Cu(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)(4,5-bis(diphenylphosphino)-9,9-dimethylxanthene)](PF6)

Conditions
ConditionsYield
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In dichloromethane Schlenk technique; Reflux;
Stage #2: Bathocuproine In dichloromethane at 20℃; Schlenk technique; Reflux;
93%
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In dichloromethane Inert atmosphere; Schlenk technique; Reflux;
Stage #2: Bathocuproine In dichloromethane Inert atmosphere; Schlenk technique; Reflux;
93%
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In dichloromethane at 20℃;
Stage #2: Bathocuproine In dichloromethane at 20℃;
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In dichloromethane Inert atmosphere; Reflux;
Stage #2: Bathocuproine In dichloromethane for 3h; Inert atmosphere; Reflux;
bis(1,5-cyclooctadiene)nickel (0)
1295-35-8

bis(1,5-cyclooctadiene)nickel (0)

Bathocuproine
4733-39-5

Bathocuproine

Ni(bathocuproine)2
1508299-90-8

Ni(bathocuproine)2

Conditions
ConditionsYield
In tetrahydrofuran at 60℃; for 12h; Inert atmosphere; Glovebox;93%
tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

2,6-dimethylphenyl isonitrile
119072-54-7, 2769-71-3

2,6-dimethylphenyl isonitrile

Bathocuproine
4733-39-5

Bathocuproine

[Cu(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)(2,6-dimethylphenylisocyanide)2]PF6

[Cu(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)(2,6-dimethylphenylisocyanide)2]PF6

Conditions
ConditionsYield
In dichloromethane for 1h;93%
C34H36CuN4(1+)*F6P(1-)

C34H36CuN4(1+)*F6P(1-)

Bathocuproine
4733-39-5

Bathocuproine

(2,9-dimesityl-1,10-phenanthroline)(bathocuproine)copper(I) hexafluorophosphate

(2,9-dimesityl-1,10-phenanthroline)(bathocuproine)copper(I) hexafluorophosphate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 0.5h;91%
Bathocuproine
4733-39-5

Bathocuproine

4-methyl-N-(2-(7-phenylindolo[1,2-a]quinazolin-9-yl)phenyl)benzenesulfonamide

4-methyl-N-(2-(7-phenylindolo[1,2-a]quinazolin-9-yl)phenyl)benzenesulfonamide

7-phenyl-13-tosyl-13H-quinazolino[1',2':1,5]pyrrolo[2,3-b]carbazole

7-phenyl-13-tosyl-13H-quinazolino[1',2':1,5]pyrrolo[2,3-b]carbazole

Conditions
ConditionsYield
With sodium acetate; palladium diacetate In 1,3,5-trimethyl-benzene at 100℃; for 6h;91%
tetrakis(actonitrile)copper(I) hexafluorophosphate
64443-05-6

tetrakis(actonitrile)copper(I) hexafluorophosphate

2,2′-bis(diphenylphosphino)-1,1′-binaphthalene.

2,2′-bis(diphenylphosphino)-1,1′-binaphthalene.

Bathocuproine
4733-39-5

Bathocuproine

[Cu(bathocuproine)(binap)]PF6

[Cu(bathocuproine)(binap)]PF6

Conditions
ConditionsYield
Stage #1: tetrakis(actonitrile)copper(I) hexafluorophosphate; 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene. In dichloromethane Schlenk technique; Reflux;
Stage #2: Bathocuproine In dichloromethane at 20℃; Schlenk technique; Reflux;
90%
Bathocuproine
4733-39-5

Bathocuproine

copper(I) bromide
7787-70-4

copper(I) bromide

(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)CuBr

(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)CuBr

Conditions
ConditionsYield
In acetonitrile at 20℃; Inert atmosphere;90%
tetrafluoroboric acid diethyl ether
67969-82-8

tetrafluoroboric acid diethyl ether

Bathocuproine
4733-39-5

Bathocuproine

[(Bathocuproine)H2](BF4)2

[(Bathocuproine)H2](BF4)2

Conditions
ConditionsYield
In acetone for 0.583333h;90%
nickel(II) bromide diethylene glycol dimethyl ether

nickel(II) bromide diethylene glycol dimethyl ether

Bathocuproine
4733-39-5

Bathocuproine

(2,9-dimethyl-4,7-diphenyl-1,10-phenantroline)NiBr2
326822-02-0

(2,9-dimethyl-4,7-diphenyl-1,10-phenantroline)NiBr2

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 46h; Inert atmosphere; Sealed tube;90%
silver hexafluoroantimonate

silver hexafluoroantimonate

Bathocuproine
4733-39-5

Bathocuproine

C52H40AgN4(1+)*F6Sb(1-)

C52H40AgN4(1+)*F6Sb(1-)

Conditions
ConditionsYield
In dichloromethane at 20℃; for 16h; Inert atmosphere; Glovebox; Schlenk technique;90%
copper(II) nitrate trihydrate

copper(II) nitrate trihydrate

Bathocuproine
4733-39-5

Bathocuproine

C52H40CuN4(2+)*2NO3(1-)

C52H40CuN4(2+)*2NO3(1-)

Conditions
ConditionsYield
In dichloromethane; acetone90%
2-oxoindole
59-48-3

2-oxoindole

Bathocuproine
4733-39-5

Bathocuproine

3-hydroxy-3-((9-methyl-4,7-diphenyl-1,10-phenanthrolin-2-yl)methyl)indolin-2-one

3-hydroxy-3-((9-methyl-4,7-diphenyl-1,10-phenanthrolin-2-yl)methyl)indolin-2-one

Conditions
ConditionsYield
With iron(II) acetate In N,N-dimethyl-formamide at 80℃; for 5h; Green chemistry;90%
potassium hexafluorophosphate
17084-13-8

potassium hexafluorophosphate

cis-bis-(2,2′-bipyridine) dichlororuthenium(II) dihydrate

cis-bis-(2,2′-bipyridine) dichlororuthenium(II) dihydrate

Bathocuproine
4733-39-5

Bathocuproine

[Ru(bpy)2(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)](PF6)2

[Ru(bpy)2(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)](PF6)2

Conditions
ConditionsYield
Stage #1: cis-bis-(2,2′-bipyridine) dichlororuthenium(II) dihydrate; Bathocuproine In 1,2-dimethoxyethane at 260℃; for 6h;
Stage #2: potassium hexafluorophosphate In water
89%
Bathocuproine
4733-39-5

Bathocuproine

2,9-dicarboxaldehyde-4,7-diphenyl-1,10-phenanthroline

2,9-dicarboxaldehyde-4,7-diphenyl-1,10-phenanthroline

Conditions
ConditionsYield
With selenium(IV) oxide In 1,4-dioxane; water at 110℃; for 2h;88%
With selenium(IV) oxide In 1,4-dioxane at 80℃; for 2h; Inert atmosphere; Sealed tube;85%
tetrakis(acetonitrile)copper(I)tetrafluoroborate

tetrakis(acetonitrile)copper(I)tetrafluoroborate

Bathocuproine
4733-39-5

Bathocuproine

bis(diphenylphosphino)acetylene
5112-95-8

bis(diphenylphosphino)acetylene

[Cu2(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)2(μ-bis(diphenylphosphino)acetylene)2](BF4)2

[Cu2(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline)2(μ-bis(diphenylphosphino)acetylene)2](BF4)2

Conditions
ConditionsYield
Stage #1: tetrakis(acetonitrile)copper(I)tetrafluoroborate; bis(diphenylphosphino)acetylene In dichloromethane; acetonitrile for 0.5h; Inert atmosphere;
Stage #2: Bathocuproine In dichloromethane; acetonitrile for 1h; Inert atmosphere;
88%

4733-39-5Relevant articles and documents

Synthesis and Photochemical Properties of Manganese(I) Tricarbonyl Diimine Complexes Bound to Tetrazolato Ligands

Stout, Matthew J.,Stefan, Alessandra,Skelton, Brian W.,Sobolev, Alexandre N.,Massi, Massimiliano,Hochkoeppler, Alejandro,Stagni, Stefano,Simpson, Peter V.

supporting information, p. 292 - 298 (2020/01/25)

Ten manganese(I) tricarbonyl diimine complexes bound to variably functionalised 5-aryl-tetrazolato ligands were prepared, and their photochemical properties were investigated. Upon exposure to light at 365 nm, each complex decomposed to its free diimine and tetrazolato ligands, simultaneously dissociating three CO ligands, as evidenced by changes in the IR spectra of the irradiated complexes over time. The anti-bacterial properties of one of these complexes were tested against Escherichia coli. While the complex displayed no effect on the bacterial growth in the dark, pre-irradiated solutions inhibited bacterial growth. Comparative studies revealed that the antibacterial properties originate from the presence of free 1,10-phenanthroline.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4733-39-5